Robert L. Rosiello - Jun 5, 2025 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Robert L. Rosiello
Stock symbol
SANA
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/9/2025, 04:40 PM
Previous filing
Oct 4, 2024
Next filing
Aug 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rosiello Robert L. Director C/O SANA BIOTECHNOLOGY, INC., 188 EAST BLAINE STREET, SUITE 400, SEATTLE /s/ Bernard J. Cassidy, Attorney-in-Fact for Robert L. Rosiello 2025-06-09 0001645041

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +115K $0.00 115K Jun 5, 2025 Common Stock 115K $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 36 equal monthly installments beginning on July 5, 2025, provided that the reporting person provides continuous service to Sana Biotechnology, Inc. through each such date.